Skip to main content
Science|Business

Bringing together industry, research and policy

Menu
  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers
  • All
  • R&D Policy
    • Technology transfer
    • Horizon Europe
    • Start-ups
    • Brexit
    • International news
    • European Research Council
    • Universities
    • EU budget
    • Research and innovation gap
    • FP10
    • European Institute of Innovation and Technology
    • Intellectual property
    • Patents
    • European Research Area
    • European Innovation Council
    • SMEs
    • Research infrastructures
    • Partnerships
    • Planning FP10
    • Open science
    • Industry
    • Sovereignty
    • Missions
    • Cohesion policy
    • Careers
    • Basic science
    • Assessment
    • Erasmus
    • Synergies
  • Health
    • COVID-19
    • Life sciences
    • Drug development
    • Biotech
    • Vaccines
    • Clinical trials
    • Medical technology
    • Antimicrobial resistance
  • R&D Funding
  • Energy
    • Renewables
    • Hydrogen
    • Nuclear fusion
    • Batteries
    • Mobility
  • Digital
    • ICT
    • AI
    • Quantum computing
    • Data
    • Semiconductors
    • Super computers
    • Robotics
  • Climate
    • Green technology
    • Low-carbon
    • Circular economy
    • Agrifood
    • Biodiversity
    • Oceans
  • Defence
    • European Defence Fund
    • Dual use
    • Aerospace
    • Cybersecurity
    • European Space Agency
  • By Table.Media

Constraints of the pandemic inspired improvements in clinical trial processes

Constraints of the pandemic inspired improvements in clinical trial processes

Clinical trials were halted as COVID-19 took hold. But inability to see patients face-to-face has inspired the use of technology to monitor patients remotely, leading to improvements that are here to stay

13 Sep 2022
News
LIVE BLOG: R&D response to COVID-19 pandemic

LIVE BLOG: R&D response to COVID-19 pandemic

  • Two new studies add to evidence that SARS-CoV-2 jumped to humans at the Wuhan seafood market
  • New research advances the prospect of a COVID-19 vaccine that protects against all variants
  • EMA’s Emergency Task Force starts review of sabizabulin for treating COVID-19
28 Jul 2022
Live Blog
LIVE BLOG: R&D response to COVID-19 pandemic (archived)
Covid 19 blog

LIVE BLOG: R&D response to COVID-19 pandemic (archived)

  • COVID-19 prompted dramatic changes in another respiratory virus
  • AI reveals hidden features on chest scans of people with Long Covid
  • Own goal: despite fewer fans and social distancing, football matches spread COVID-19 in Germany
02 Jun 2022
Live Blog
Viewpoint: Artificial intelligence poised to play greater role in science

Viewpoint: Artificial intelligence poised to play greater role in science

Global survey shows researchers in increasing numbers are looking to AI to support and speed up their work

28 Apr 2022
News

Support for non-peer reviewed scientific paper preprints is soaring

26 Apr 2022
News
Viewpoint: The EU needs to play bigger role in pandemic preparedness - and CEPI is the place to start

Viewpoint: The EU needs to play bigger role in pandemic preparedness - and CEPI is the place to start

The Coalition for Pandemic Preparedness played a key part in speeding development of COVID-19 vaccines. It now needs support over the next five years to end the pandemic and be ready for future infectious disease outbreaks

04 Mar 2022
News
Vaccine patent standoff mars EU-Africa summit

Vaccine patent standoff mars EU-Africa summit

The EU and the African Union agreed on a new innovation agenda, but campaigners still believe the EU could do more to help Africa manufacture its own vaccines

22 Feb 2022
News
Viewpoint: To deal with global challenges, open access publishing must be the new normal

Viewpoint: To deal with global challenges, open access publishing must be the new normal

As the development of COVID-19 vaccines illustrates, freely sharing publications and data speeds the translation of research - for public good. With the case proved, there must be a renewed push for open access

03 Feb 2022
News
Advertising
Conspiracy thinking: 25% of Europeans say the moon landing never happened

Conspiracy thinking: 25% of Europeans say the moon landing never happened

A survey by the TRESCA EU research project details how scientific dis- and mis-information abounds. The group is working on tools to help manage this digital plague of our era

25 Jan 2022
More news about
TRESCA
New Year’s resolution: Research group aims to fix the way the world collaborates on technology

New Year’s resolution: Research group aims to fix the way the world collaborates on technology

Facing COVID-19 and climate challenges, a group of international research leaders is pushing the G7 to create a new framework for precompetitive collaboration

04 Jan 2022
News

Pagination

  • Previous page ‹‹
  • You're on Page 2
  • Next page ››

Get the Science|Business newsletters

newsletter iconReceive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 

  Sign up for the Funding Newswire

  Sign up for the Policy Bulletin

  Sign up for The Widening

Funding Newswire subscription

align-right

Follow where the public and private R&I money is going and which collaborative opportunities you can pursue. 

Subscribe today

Log in

Find out more about the Science|Business Network

Network iconA unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.

  Why join?

  Become a member

Home

Privacy   |   T&Cs   |   © 2025 Science Business Publishing Ltd.

  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers